Myriad Genetics (MYGN) Change in Receivables (2009 - 2026)
Myriad Genetics (MYGN) reported Change in Receivables of $8.7 million for Q1 2026, up 1187.5% year-over-year from $675728.2 in Q1 2025, and up 434.62% quarter-over-quarter from -$2.6 million in Q4 2025.
Myriad Genetics (MYGN) Change in Receivables (2009 - 2026) Analysis & Trends
Myriad Genetics (MYGN) has 18 years of Change in Receivables data on file, last reported at $8.7 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $8.7 million, up 1187.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 17.5% YoY), and the FY2025 annual result was -$6.2 million, down 171.26% from the prior year.
- Change in Receivables rose to $8.7 million in Q1 2026 per MYGN's latest filing, from -$2.6 million in the prior quarter.
- Over five years, Change in Receivables peaked at $17.5 million in Q1 2023 and troughed at -$19.0 million in Q3 2025.
- A 5-year average of $2.0 million and a median of $600000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables slumped 1120.0% in 2022, then jumped 2600.0% in 2025.
- A 5-year view of Change in Receivables shows it stood at -$2.5 million in 2022, then jumped by 52.0% to -$1.2 million in 2023, then sank by 233.33% to -$4.0 million in 2024, then soared by 35.0% to -$2.6 million in 2025, then surged by 434.62% to $8.7 million in 2026.
- Business Quant data shows MYGN's Change in Receivables at $8.7 million in Q1 2026, -$2.6 million in Q4 2025, and -$19.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | - |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -12.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 121.07 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | - |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -65.11 Mn |
| 10 | Myriad Genetics | 424.93 Mn | 300.53 Mn | 137.60 Mn | 8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.70 Mn |
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Dec 31, 2025 | -2.60 Mn |
| Sep 30, 2025 | -19.00 Mn |
| Sep 30, 2025 | -19.00 Mn |
| Jun 30, 2025 | 16.20 Mn |
| Jun 30, 2025 | 16.20 Mn |
| Mar 31, 2025 | -800,000.00 |
| Mar 31, 2025 | -800,000.00 |
| Dec 31, 2024 | -4.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Sep 30, 2024 | 8.20 Mn |
| Jun 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 600,000.00 |
| Mar 31, 2024 | 3.90 Mn |
| Mar 31, 2024 | 3.90 Mn |
| Dec 31, 2023 | -1.20 Mn |
| Dec 31, 2023 | -1.20 Mn |